We are live on
!
Find out more
GA
Gagnon Advisors Portfolio holdings
AUM
$136M
1-Year Est. Return
21.55%
This Fund
S&P 500
This Quarter
Est. Return
+15.17%
1 Year Est. Return
+21.55%
3 Year Est. Return
+78.18%
5 Year Est. Return
+93.01%
10 Year Est. Return
+1,298.31%
AUM
$163M
AUM Growth
+$24M
(+17%)
Cap. Flow
+$13.2M
Cap. Flow
% of AUM
8.11%
Top 10 Holdings %
Top 10 Hldgs %
58.86%
Holding
30
New
4
Increased
4
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$3.17M |
| 2 |
CMLFU
CM Life Sciences, Inc. Unit
CMLFU
|
+$2.5M |
| 3 |
LL
LL Flooring Holdings, Inc.
LL
|
+$2.23M |
| 4 |
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
|
+$1.99M |
| 5 |
BioLife Solutions
BLFS
|
+$1.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSLT
CASTLIGHT HEALTH, INC.
CSLT
|
+$814K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.17% |
| 2 | Healthcare | 27.07% |
| 3 | Industrials | 18.26% |
| 4 | Energy | 7.28% |
| 5 | Real Estate | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
CALL
Merck
MRK
$321B
| $1.59M | 0.98% |
+20,122
| New | +$1.58M |
|
|
APEN
27
DELISTED
Apollo Endosurgery, Inc.
APEN
| $1.55M | 0.95% |
919,846
+400,000
| +77% | +$603K |
|
|
GFNCP
28
DELISTED
General Finance Corporation Cumulative Redeemable Perpetual Preferred Series C
GFNCP
| $1.36M | 0.83% |
13,329
| – | – |
|
29
Celcuity
CELC
$4.27B
| $823K | 0.51% |
141,811
| – | – |
|
|
CNF
30
CNFinance Holdings
CNF
$37.1M
| $576K | 0.35% |
18,163
| – | – |
|
Similar funds
WF
MWA
SSCM
BDCMI
WA
LCM
NVCHI
GPWA
Gagnon Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Gagnon Advisors held 30 positions worth $163M, up 17% from $139M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Gagnon Advisors deployed $13.2M of net new capital in Q3 2020, opening 4 new positions and adding to 4 existing holdings. Its largest new stake was Merck: 40,416 shares worth $3.2M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was CASTLIGHT HEALTH, INC., an estimated $814K trimmed.
- Gagnon Advisors's largest Q3 2020 buy was Merck: 40,416 shares worth $3.2M.
- Gagnon Advisors added most to LL Flooring Holdings, Inc. in Q3 2020, an estimated $2.23M increase.
- Gagnon Advisors's biggest Q3 2020 reduction was CASTLIGHT HEALTH, INC., cutting an estimated $814K.
- Gagnon Advisors's ten largest holdings make up 59% of its $163M portfolio in Q3 2020.
- Gagnon Advisors opened 4 new positions and closed 0 in Q3 2020.
- Gagnon Advisors's portfolio value rose 17% quarter-over-quarter to $163M.
Based on Gagnon Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.